Roche CEO reported that they have done considerably well in year 2009, there drug Tamiflu is expected to generate more than $2.2 Billion in sales and after they acquired Genentech they have some more drugs to fill in their clinical pipeline.
For more information please click on the following link
http://in.reuters.com/article/rbssHealthcareNews/idINLDE5BJ06H20091220
No comments:
Post a Comment